0 items USD 0.00Search
- Did you mean
- psoriasis arthritis
Your search for "psoriatic arthritis" gave back 2456 results.
Rare inflammatory disease treatment refers to specialized therapies for uncommon chronic inflammatory conditions caused by immune system...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 2,900.00
The global Rheumatic Disorders Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
August 2024
Price: USD 3,480.00
The global Tumor Necrosis Factor Inhibitor Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Tumor...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
June 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market size was valued at USD 28030 million in 2023 and is forecast to a readjusted size of USD 35720 million by...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
July 2024
Price: USD 3,480.00
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2024
Price: USD 2,900.00
TNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2024
Price: USD 2,900.00
The global Etoricoxib Intermediate market size was valued at US$ million in 2023. With growing demand in downstream market, the Etoricoxib...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
February 2024
Price: USD 3,660.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market was valued at US$ 27240 million in 2023 and is anticipated to reach US$ 35210 million by 2030, witnessing a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
TNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
April 2023
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2023
Price: USD 2,900.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
June 2023
Price: USD 4,900.00
Rare autoinflammatory diseases drugs are medications designed to treat conditions where the body's immune system mistakenly attacks itself,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 2,900.00
Ìý
